Squarepoint’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Sell |
134,221
-131,864
| -50% | -$1.17M | ﹤0.01% | 1431 |
|
2025
Q1 | $2.08M | Buy |
266,085
+138,496
| +109% | +$1.08M | ﹤0.01% | 1144 |
|
2024
Q4 | $1.34M | Sell |
127,589
-1,026
| -0.8% | -$10.8K | ﹤0.01% | 1369 |
|
2024
Q3 | $1.69M | Buy |
+128,615
| New | +$1.69M | ﹤0.01% | 1197 |
|
2023
Q4 | – | Sell |
-14,582
| Closed | -$150K | – | 2499 |
|
2023
Q3 | $150K | Buy |
+14,582
| New | +$150K | ﹤0.01% | 2183 |
|
2021
Q3 | – | Sell |
-28,162
| Closed | -$190K | – | 2229 |
|
2021
Q2 | $190K | Buy |
28,162
+16,194
| +135% | +$109K | ﹤0.01% | 2253 |
|
2021
Q1 | $108K | Sell |
11,968
-44,698
| -79% | -$403K | ﹤0.01% | 2341 |
|
2020
Q4 | $379K | Sell |
56,666
-4,499
| -7% | -$30.1K | ﹤0.01% | 1699 |
|
2020
Q3 | $308K | Buy |
+61,165
| New | +$308K | ﹤0.01% | 1655 |
|